factor

(redirected from GM-CSF)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Related to GM-CSF: interleukin, Cytokines, Sargramostim

Factor

An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

factor

n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

factor

(Commission merchant), noun agent, broker, commercial agent, delegate, deputy, envoy, interagent, manager, medium, middleman, one who sells for factorage, proctor, procurator, representative
Associated concepts: consignee, factors' lien

factor

(Ingredient), noun additive, agent, aid, aspect, cause, component, constituent, constitutive element, content, contributing force, determinant, element, elementary unit, feature, integral part, part, portion, segment, unit
See also: aspect, broker, cause, characteristic, component, constituent, dealer, deputy, determinant, element, feature, ingredient, member, part, plenipotentiary, portion, procurator, reason, represent, substitute

factor

1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
References in periodicals archive ?
GM-CSF and IL-10, the two cytokines significantly affected by p-NP, are important mediators in human pregnancy (Gotsch et al.
In conclusion, thunberginol B inhibited the expression of various cytokines such as ILs-2, 3, 4 and 13, TNF-[alpha] and GM-CSF as determined using a cDNA microarray and RT-PCR.
After the GM-CSF genes were introduced in the cells, the cancer cells were irradiated to ensure their safe injection into the patient.
These trials, supported and conducted by the National Institutes of Health HIV Vaccine Trials Network, have set the stage for the second-generation GM-CSF co-expressing vaccine to move from its initial Phase 1 safety testing slated to start in March of this year to a Phase 2b efficacy trial in participants who are at high risk of exposure to HIV.
LPS stimulation increased message levels of IL-1[beta], IL-6, GM-CSF,, iNOS, MCP-1, MIP-2, and TNF-[alpha] but not those of ICAM-1, IL-10, and TGF-[beta]1.
Furthermore, the study demonstrates a highly statistically-significant association between overall survival and specific vaccine-induced anti-tumor GM-CSF cytokine (T-cell) responses.
KB003 is an anti-GM-CSF mAb that KaloBios is evaluating in oncology indications where GM-CSF may play a key role, such as chronic myelomonocytic leukemia (CMML).
University of South Florida researchers found that the protein, GM-CSF, likely stimulates the body's natural scavenger cells to attack and remove Alzheimer's amyloid deposits in the brain.
It also induces tumour cells to secrete GM-CSF, a powerful immune stimulator, potentially enhancing the destruction of both injected and metastatic tumour deposits.
Recent studies have indicated that the cytokine GM-CSF plays a central role in the development of rheumatoid arthritis.
Biotechnology, companies now can manufacture human GM-CSF and G-CSF in yeast or bacteria, and researchers have begun testing the usefulness of these two recombinant growth factors in various medical conditions, including AIDS (SN: 9/12/87, p.
The present Competitive Intelligence Report about G-CSF & GM-CSF products in the pipeline and off-patent products provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets and products in non-regulated markets, biosimilars (biogenerics, follow-on biologics) and next generation, longer acting products or new uses of G-CSF as of January 2011.